Chengyitong (300430.SZ) released its 2023 annual report. The company achieved operating income of 11 during the reporting period...
According to Zhitong Finance App, Chengyitong (300430.SZ) released its 2023 annual report. During the reporting period, the company achieved operating income of 1,176 billion yuan, an increase of 20.63%; net profit attributable to shareholders of listed companies was 170 million yuan, an increase of 36.30%; net profit attributable to shareholders of listed companies deducted non-recurring profit and loss of 149 million yuan, an increase of 31.20% year on year; basic earnings per share were 0.63 yuan/share.
The company's profit distribution plan reviewed and approved by the board of directors is as follows: using 273,184,096 as a base, a cash dividend of 0.55 yuan (tax included) to all shareholders, 0 bonus shares (tax included) for every 10 shares, and a capital reserve fund to transfer 0 shares to all shareholders for every 10 shares.
In 2023, thanks to economic recovery and development, the company's project operation efficiency improved markedly. At the same time, “internal and external repair” measures promoted the steady development of the company's intelligent manufacturing business. Externally, the company adheres to the “field expansion” development concept, continues to strengthen the development of emerging business fields on the basis of maintaining existing advantageous businesses, and firmly grasps new opportunities in synthetic biotechnology and green biomantry. Internally, the company continues to consolidate its internal skills, accelerate product category expansion, use technology to promote marketing, achieve forward sales movement, expand service radius, and continuously improve project undertaking capabilities.